CLARO
LIVE

Serial Number

79278076

Owner

TESSENDERLO GROUP N.V.

Attorney

Bradley M. Stohry

Filing Date

Oct 10, 2019

Add to watchlist:

No watchlists yet
View on USPTO

CLARO Trademark

Serial Number: 79278076 • Registration: 6641396

CLARO is a trademark filed by TESSENDERLO GROUP N.V. on October 10, 2019. The trademark is classified under Class 1 (Chemicals), Class 2 (Paints), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

TESSENDERLO GROUP N.V. (4 trademarks)

Troonstraat 130
Brussel B-1050 , BE

Entity Type: 32

Trademark Details

Filing Date

October 10, 2019

Registration Date

February 15, 2022

Published for Opposition

November 30, 2021

Goods & Services

Chemical preparations for medical purposes, namely, bio-inks for the engineering of biological tissues for medical and veterinary purposes; Biological preparations for medical purposes, namely bio-inks for the creation of epithelial, connective, muscular and nervous tissues; Biological tissue cultures for medical purposes; Biological tissue cultures for veterinary purposes; Cultures of microorganisms for medical or veterinary use; Engineered surgical transplants in the nature of implants consisting of living tissues; Transplants, namely implants comprising living tissues; Natural biomaterials for augmentation or subsequent implantation of bone and tissue for medical purposes

Printing compositions, namely printers' pastes, ink, thinners, thickeners, coatings, preservatives and colorants; Ink for bioprinting namely printers' pastes, ink, thinners, thickeners, coatings, preservatives and colorants; Bio-ink for 3D bioprinting namely ink, thinners, thickeners, coatings, preservatives and colorants; Ink cartridges for 3D printers, filled with bio-ink consisting of a mixture of ink, thinners, thickeners, coatings, preservatives and colorants; Bio-ink consisting of a mixture of namely ink, thinners, thickeners, coatings, preservatives and colorants used in the manufacture of living tissue

Industrial chemicals; Protein in raw material form for scientific and medical research, not intended for diagnostic or therapeutic use, nor administration to animals or humans; Gelatine for industrial purposes in the nature of gelatinous spongy chunks, powders, beads, granulates, gels, and hydrogels; Collagen for industrial purposes; peptides for industrial purposes; chemical preparations for scientific purposes, other than for medical or veterinary use; chemicals for use in biotechnological product development; biological preparations, other than for medical or veterinary purposes, for use in industry and science; biological preparation for use in cell cultures, other than for medical or veterinary use; biological tissue cultures, other than for medical or veterinary purposes; chemical preparations used in the manufacture of engineered living tissue; chemical preparations used in the manufacture of scaffolds for tissue engineering; biopolymers used in the manufacture of engineered living tissue; biological preparations used in the manufacture of engineered living tissue; Chemicals for use in the production of inks for 3d printing, namely chemical ingredients for use in the manufacture of bio-inks; chemicals for use in the production of biological inks for 3d printing; Chemical preparations, namely preparations consisting of a mixture of gelling agents, proteins, gelatines, peptides, collagen, biopolymers, collagen hydrolysates, moistening agents, additives and preservatives, for use in 3d bioprinting of tissues and organs, not intended for diagnostic or therapeutic use; Biological preparations, namely, preparations consisting of a mixture of gelling agents, proteins, gelatines, peptides, collagen, biopolymers, collagen hydrolysates, moistening agents, additives and preservatives, for use in 3d bioprinting of tissues and organs, not intended for diagnostic or therapeutic use; biological tissue specimens for use in scientific research, not intended for diagnostic or therapeutic use

Artificial biomaterials for manufacturing of bone and tissue for medical purposes, namely artificial bones and artificial epithelial, connective, muscular and nervous tissues for implantation

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Aug 9, 2022 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jul 20, 2022 FICS
FINAL DISPOSITION PROCESSED
Jul 20, 2022 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 15, 2022 FICR
REGISTERED-PRINCIPAL REGISTER
Feb 15, 2022 R.PR
NOTIFICATION PROCESSED BY IB
Dec 5, 2021 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 30, 2021 NPUB
PUBLISHED FOR OPPOSITION
Nov 30, 2021 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 10, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Nov 10, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 10, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 25, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 22, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 22, 2021 CRFA
ASSIGNED TO LIE
Sep 22, 2021 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Sep 16, 2021 ERSI
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jul 24, 2021 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 7, 2021 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jul 7, 2021 OPNR
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
May 25, 2021 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Oct 27, 2020 GNS3
LETTER OF SUSPENSION E-MAILED
Oct 27, 2020 GNSL
SUSPENSION LETTER WRITTEN
Oct 27, 2020 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 3, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 3, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 3, 2020 TROA
NEW REPRESENTATIVE AT IB RECEIVED
Aug 13, 2020 NREP
REFUSAL PROCESSED BY IB
Mar 28, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 9, 2020 RFCS
REFUSAL PROCESSED BY MPU
Mar 9, 2020 RFRR
APPLICATION FILING RECEIPT MAILED
Feb 14, 2020 MAFR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 13, 2020 RFCR
NON-FINAL ACTION WRITTEN
Feb 12, 2020 CNRT
ASSIGNED TO EXAMINER
Feb 10, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 10, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 6, 2020 REPR